Microsoft Excel LibreOffice Calc

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)


Statement of Comprehensive Income

Beginner level

Vertex Pharmaceuticals Inc., consolidated statement of comprehensive income

US$ in thousands

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net income (loss) 1,176,810  2,087,103  91,635  (84,031) (588,181)
Unrealized holding gains (losses) on marketable securities, net of tax 1,039  58  6,954  17,395  249 
Unrealized gains (losses) on foreign currency forward contracts, net of tax (14,003) 27,438  (26,530) 7,736  1,767 
Foreign currency translation adjustment 10,332  8,855  (13,169) (5,782) (1,109)
Changes in other comprehensive income (loss) (2,632) 36,351  (32,745) 19,349  907 
Comprehensive income (loss) 1,174,178  2,123,454  58,890  (64,682) (587,274)
Comprehensive (income) loss attributable to noncontrolling interest —  9,793  171,849  (28,021) 31,847 
Comprehensive income (loss) attributable to Vertex 1,174,178  2,133,247  230,739  (92,703) (555,427)

Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16).

Comprehensive income item Description The company
Net income (loss) attributable to Vertex The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Vertex Pharmaceuticals Inc.’s net income (loss) attributable to Vertex increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.
Comprehensive income (loss) attributable to Vertex Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Vertex Pharmaceuticals Inc.’s comprehensive income (loss) attributable to Vertex increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.